In the ongoing conversation about healthcare affordability, drug price reduction has emerged as a crucial focus for policymakers and citizens alike.Recently, President Trump signed an Executive Order aimed at pressing pharmaceutical companies to voluntarily lower their prices, a move that seeks to combat the alarming trend of U.S.